Increased cerebral extracellular adenosine and decreased PGE2 during ethanol-induced inhibition of FBM.
Adenosine and PGE2 are neuromodulators, both of which inhibit fetal breathing movements (FBM). Although circulating PGE2 has been implicated as a mediator of ethanol-induced inhibition of FBM in the late-gestation ovine fetus, a role for adenosine has not been examined. The objective of this study was to determine the effect of maternal ethanol infusion on ovine fetal cerebral extracellular fluid adenosine and PGE2 concentrations by using in utero microdialysis and to relate any changes to ethanol-induced inhibition of FBM. Dialysate samples were obtained from the fetal parietal cortex over 70 h after surgery to determine steady-state extracellular fluid adenosine and PGE2 concentrations. On each of postoperative days 3 and 4, after a 2-h baseline period, ewes received a 1-h infusion of ethanol (1 g/kg maternal body wt) or an equivalent volume of saline, and the fetus was monitored for a further 11 h with 30-min dialysate samples collected throughout. Immediately after surgery, dialysate PGE2 and adenosine concentrations were 3.7 +/- 0.7 and 296 +/- 127 nM, respectively. PGE2 did not change over the 70 h, whereas adenosine decreased to 59 +/- 14 nM (P < 0.05) at 4 h and then remained unchanged. Ethanol decreased dialysate PGE2 concentration for 2 h (3.3 +/- 0.3 to 1.9 +/- 0.4 nM; P < 0.05) and increased adenosine concentration for 6 h (87 +/- 13 to a maximum of 252 +/- 59 nM, P < 0.05). Ethanol decreased FBM incidence from 47 +/- 7 to 16 +/- 5% (P < 0.01) for 8 h. Saline infusion did not change dialysate adenosine or PGE2 concentrations or FBM incidence. These data are consistent with the hypothesis that fetal cerebral adenosine, and not PGE2, is the primary mediator of ethanol-induced inhibition of FBM at 123 days of gestation in sheep.
Watson
C S
CS
Departments of Physiology and of Obstetrics and Gynaecology, Medical Research Council Group in Fetal and Neonatal Health and Development, Lawson Research Institute, University of Western Ontario, London, Ontario N6A 4V2, Canada M5S 1A8.
White
S E
SE
Homan
J H
JH
Kimura
K A
KA
Brien
J F
JF
Fraher
L
L
Challis
J R
JR
Bocking
A D
AD
D000241:Adenosine / Q000378:metabolism*; D000704:Analysis of Variance; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000196:embryology*; D002245:Carbon Dioxide / Q000097:blood; D015232:Dinoprostone / Q000378:metabolism*; D000431:Ethanol / Q000008:administration & dosage / Q000494:pharmacology*; D005110:Extracellular Space / Q000502:physiology; D005260:Female; D005333:Fetus / Q000502:physiology*; D006454:Hemoglobins / Q000378:metabolism; D007262:Infusions, Intravenous; D007773:Lactates / Q000097:blood; D008431:Maternal-Fetal Exchange; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011247:Pregnancy; D015656:Respiratory Mechanics / Q000187:drug effects / Q000502:physiology*; D012756:Sheep
D001786:Blood Glucose; D006454:Hemoglobins; D007773:Lactates; D002245:Carbon Dioxide; D000431:Ethanol; D000241:Adenosine; D015232:Dinoprostone; D010100:Oxygen